ASH 2022 Conference Coverage
ASH 2022 Results from BRUIN: A Phase 1/2 Study of Pirtobrutinib, a Highly Selective, Non-Covalent BTKi in Richter Transformation
By
ASH 2022 Conference Coverage
FEATURING
Nirav Shah
By
ASH 2022 Conference Coverage
FEATURING
Nirav Shah
Login to view comments.
Click here to Login
